Biosmith Pharmachem Private Limited
About Biosmith Pharmachem Private Limited
Data last updated:
Biosmith Pharmachem Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 June 2021.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2021PTC382752.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Divyang Lohariwala and Shreekant Bagaria.
Its last annual general meeting (AGM) was held on 29 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Unit No. Fc – 303 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.63 Cr, a growth of 124% compared to the previous year. For the same year it recorded a net profit of ₹13,388 (net margin 0.1%) and EBITDA of ₹18,416 (EBITDA margin 0.1%).
Company details
Contact details
Biosmith Pharmachem Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressUnit No. Fc – 303 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Biosmith Pharmachem is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biosmith Pharmachem Private Limited, buy the company report.
Financials of Biosmith Pharmachem Private Limited
FY 2023 filings availableBiosmith Pharmachem Private Limited reported revenue of ₹1.63 Cr (up 124% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 124% in the latest year. EBITDA rose 18% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹18,416 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹13,388 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | |
| Net Profit Margin | 0.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Biosmith Pharmachem Private Limited, buy the company report.
Board of directors of Biosmith Pharmachem Private Limited
Biosmith Pharmachem has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divyang Lohariwala Also directs: Biosmith Lifesciences Private Limited | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
| Shreekant Bagaria Also directs: Ganpati Agrovet Private Limited, Bagaria Chemicals Private Limited | Director | 25 Jun 2021 | 5 Years 4 Months | Current |
Peer comparison
Biosmith Pharmachem Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Monopharma Private Limited | ₹1.63 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Mediabex Laboratories Private Limited | ₹1.63 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Biosmith Pharmachem Private Limitedthis company | ₹1.63 Cr (FY 2023) | ₹13,388 | 0.1% | 124.0% | New Delhi, Delhi, India | |
| Sachi Pharma Private Limited | ₹1.62 Cr (FY 2024) | -15.0% | Amravati, Maharashtra, India |
To see the full peer comparison of Biosmith Pharmachem Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Biosmith Pharmachem Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biosmith Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Biosmith Pharmachem Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Biosmith Pharmachem Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Divyang Lohariwala was appointed as Director on 25 Jun 2021.
Frequently asked questions
Biosmith Pharmachem is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Biosmith Pharmachem is a company pending strike off, currently registered as a private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 June 2021 and is registered under CIN U24230DL2021PTC382752. The company may be struck off soon - caution is advised.
Biosmith Pharmachem has 2 current directors:
- Divyang Lohariwala - Director
- Shreekant Bagaria - Director
The CIN (Corporate Identification Number) of Biosmith Pharmachem is U24230DL2021PTC382752. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biosmith Pharmachem was incorporated on 25 June 2021. It is registered with the Registrar of Companies, Delhi.
The registered office of Biosmith Pharmachem is at Unit No. Fc – 303 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
The latest financial statements of Biosmith Pharmachem on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 29 September 2023. Year-wise statements from FY 2022 are in the company report.
Biosmith Pharmachem operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Biosmith Pharmachem by revenue are Monopharma Private Limited, Mediabex Laboratories Private Limited, Sachi Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Divyang Lohariwala was appointed as Director on 25 Jun 2021. Shreekant Bagaria was appointed as Director on 25 Jun 2021.
Biosmith Pharmachem can be reached at its registered office: Unit No. Fc – 303 D – Mall Plot No. A1 Netaji Subhash Place Pitampura, New Delhi, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
